Treatment of experimental endocarditis due to multidrug-resistant Enterococcus faecium with clinafloxacin and penicillin

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 1, 1996, Pages 127-132

  Zaman, Muhammad M ^a   Landman, David ^a   Burney, Sibte ^a   Quale, John M ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CLINAFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL ENDOCARDITIS; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; KIDNEY; MULTIDRUG RESISTANCE; NONHUMAN; RABBIT; SPLEEN;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; ENDOCARDITIS, BACTERIAL; ENTEROCOCCUS FAECIUM; FLUOROQUINOLONES; GRAM-POSITIVE BACTERIAL INFECTIONS; MICROBIAL SENSITIVITY TESTS; PENICILLINS; QUINOLONES; RABBITS;

EID: 0029879286     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.1.127     Document Type: Article

References (13)

1. Burney, S., Landman, D. & Quale, J. M. (1994). Activity of clinafloxacin against multidrug-resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy 38, 1668-70.
2. Dorr, M. B., Webb, C. L., Bron, N. & Vassos, A. B. (1991). Single-dose tolerance and pharmcokinetics of CI-960 (PD 127391) in healthy volunteers In Program and Abstracts of the Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, 1991. Abstract 1154, p. 291. American Society for Microbiology, Washington, DC.
3. Fernandez-Guerrero, M., Rouse, M. S., Henry, N. K., Geraci, J. E. & Wilson, W. R. (1987). In-vitro and in-vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis. Antimicrobial Agents and Chemotherapy 31, 430-3.
4. Freiden, T. R., Munsiff, S. S., Low, D. E., Willey, B. M., Williams, G., Faur, Y. et al. (1993). Emergence of vancomycin-resistant enterococci in New York City. Lancet 342, 76-9.
5. Landman, D., Mobarakai, N. K. & Quale, J. M. (1993). Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin. Antimicrobial Agents and Chemotherapy 37, 1904-8.
6. Landman, D., Quale, J. M., Mobarakai, N. K. & Zaman, M. (1995). Ampicillin plus ciprofloxacin therapy of experimental endocarditis caused by multidrug resistant Enterococcus faecium. Journal of Antimicrobial Chemotherapy 36, 253-8.
7. Livornese, L. L., Dias, S., Samel, C., Romanowski, B., Taylor, S., May, P. et al. (1992). Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Annals of Internal Medicine 117, 112-6.
8. Norrby, S. R. & Jonsson, M. (1988). Comparative in-vitro activity of PD 127,391, a new fluorinated 4-quinolone derivative. Antimicrobial Agents and Chemotherapy 32, 1278-81.
9. Quale, J. M., Landman, D. & Mobarakai, N. (1994). Treatment of experimental endocarditis due to multidrug resistant Enterococcus faecium with ciprofloxacin and novobiocin. Journal of Antimicrobial Chemotherapy 34, 797-802.
10. Sahm, D. F. & Koburov, G. T. (1989). In-vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy. Antimicrobial Agents and Chemotherapy 33, 71-7.
11. Shonekan, D., Mildvan, D. & Handwerger, S. (1992). Comparative in-vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of Gram-positive cocci. Antimicrobial Agents and Chemotherapy 36, 1570-2.
12. Vazquez, J., Perri, M. B., Thai, L. A., Donabedian, S. A. & Zervos, M. J. (1993), Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits. Journal of Antimicrobial Chemotherapy 32, 715-21
13. Whitman, M. S., Pitsakis, P. G., Zausner, A., Livornese, L. L., Osborne, A. J., Johnson, C. C. et al. (1993). Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy 37, 2069-73.